Font Size: a A A

A Case Of High Expression Of CyPA And Methotrexate Resistance And Case Of Thymoma

Posted on:2015-10-17Degree:MasterType:Thesis
Country:ChinaCandidate:Y ZhangFull Text:PDF
GTID:2134330431964950Subject:Oncology
Abstract/Summary:PDF Full Text Request
Objective:To exoplore the effect of exogenous overexpression of CyPA gene on the sensitizationto OXALIPLATIN induced apoptosis.Methods:1. CypA genes were respectively intuoduced into HCT116cells cells by liposome2000.Cellular CyPAin the transfected cells were assessd by western blot.2. MTT(4,5-dimethylth iazoleo r2,5-diphenylte trazoilumb romid,MTT)was adopted todetect the sensitivity of HCT116cells transfected with blank plasmid or targeting geneto OXALIPLATIN.3. FCM(flow cytometry) was used to detect the cell cycled is tribution and the rate ofapoptosis upon32ug/mL treatrment OXALIPLATIN for12h hours.PI staining was usedto detect apoptosis morphous of cells after treated with32ug/mL OXALIPLATIN for12hours.Rusults:1. Transform HCT116cells with recombinant plasmid pcmv-CyPA and blankplasmid,and detect instantaneously expressed product CyPAby western blot.2. Etopic expression of CyPA of HCT116-CyPA cells resulted in decreased proportionof G1stage,and increased proportion of S stage,than vector controls.3. The cell growth inhibition effects of OXALIPLATIN show that, the CyPAoverexpression groups showed higher resistance to OXALIPLATINL than the blankplasmid groups4. OXALIPLATINL induceded cell death via apoptosisin ducing effect.The apoptosisrates of blank plasmid groups and CyPA overexpression groups, after treated with32ug/ml OXALIPLATINL for12h were12.51%and6.31%. Conclusions:1. Ectopic overexpression of CyPAcould affects cell cycle tribution of HCT116.2. Ectopic overexpression of CyPAcould increase HCT116resistance to the cytotoxicityof OXALIPLATIN. Objective:to study the treatment of thymoma associated with red cell aplasticanemia.Methods:1case of thymoma after excision biopsy confirmed pathological, tumorrecurred after8years,treated with chemotherapy and immune regulation therapy.Results: after4cycles of chemotherapy (docetaxel and cisplatin for specificproject:120mg40mg d2-4), the disease progressed associated with complications: redcell aplastic anemia.After the treatment of CsA, continued to primary chemotherapyin the treatment of patients,the number of red blood cells increased.therapeuticevaluation:PR.Conclusion:After Cyclosporine immune therapy, the tumor was effectivelycontrolled, and reverse the chemotherapy drug resistance, continue to use the originalscheme after3cycles,clinical evaluation of by CT: PR...
Keywords/Search Tags:CyPA, OXALIPLATINL, HCT116Thymoma, Redcellaplasticanemia, CsA
PDF Full Text Request
Related items